National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike is a clinical research site located in Bethesda, Maryland, United States 20892.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike has participated in 8 clinical trials.
Therapeutic areas: Obstructive Coronary Artery Disease, Obstructive Peripheral Artery Disease, Structural Heart Disease.
Sponsors: National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health Clinical Center (CC).
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike has 8 clinical trials on record. Their work covers Obstructive Coronary Artery Disease, Obstructive Peripheral Artery Disease, Structural Heart Disease.
Yes — National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.